Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that severe forms of alopecia areata may be associated with poor treatment response, particularly in cases with extensive hair loss, juvenile onset, or nail changes.

This study found that short vellus hair and yellow dots are common dermoscopic findings in alopecia areata, with variations indicating disease activity or remission.

This study found that patients on maintenance hemodialysis commonly experience cutaneous symptoms, with pigmentation and nail disorders being the most prevalent.

This study found that alopecia areata was more common in males, most frequently appeared on the scalp, and typically presented as patchy hair loss.

In this study, researchers found that hair changes, particularly anagen effluvium, were the most common mucocutaneous side effects in cancer patients undergoing chemotherapy, occurring in 31.71% of cases, followed by skin, nail, and mucosal changes, highlighting the morbidity associated with antineoplastic drug side effects.

In this original study, researchers documented 121 COVID-19 cases with a wide range of mucocutaneous manifestations, some linked to internal organ damage and others to new vaccine-associated dermatoses, emphasizing the importance of rapid diagnosis to prevent potentially life-threatening systemic events.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

This article reviews the clinical features and potential associated conditions of alopecia areata, including its progression and histopathological characteristics, but reports no new clinical findings.

This case report describes a 56-year-old male with chronic watery diarrhea, hyperpigmentation, and alopecia, in whom colonoscopy revealed multiple polypoidal lesions from the distal transverse colon to the rectum.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

This diagnostic discussion reports that diffuse alopecia areata was identified in a patient with diffuse hair loss, based on specific histopathological features observed in a biopsy.

This case report describes a 60-year-old woman with Cronkhite-Canada syndrome whose symptoms and polyposis improved following prednisolone therapy, but emphasizes the need for periodic digestive tract screening due to associated cancer risks.

This abstract describes various hair and nail changes associated with HIV infection, highlighting telogen effluvium and onychomycosis as common manifestations, while noting that treatment for onychomycosis does not differ between HIV-infected and non-infected individuals.

This study found that combined therapy, including oral and topical treatments, was effective in improving severe alopecia areata, with injection site pain and facial hair changes as common side effects.

This paper reviews the diverse skin, nail, and hair changes caused by medications, highlighting hyperpigmentation, alopecia, and nail structural alterations, but reports no new data.

This case report documents a 61-year-old woman treated with erlotinib who experienced the rare side effect of cicatricial alopecia.

This report highlights the successful treatment of skin and nail manifestations in a patient with primary hypothyroidism using levothyroxine, emphasizing the role of cutaneous symptoms in identifying thyroid disease.

This review summarizes documented cases of hair and ungual changes associated with COVID-19, which may help to further understand the disease's clinical implications.

This expert consensus statement highlights that while targeted cancer therapies significantly improve patient survival, they often result in various skin toxicities, underscoring the need for early diagnosis, management, and multidisciplinary care to maintain patients' quality of life and ensure treatment continuity.

This study observed that 30.1% of older adults had nail changes, predominantly affecting the lower limbs, and hair disorders were less common, with alopecia being the only type recorded.

This article describes a case of selenium poisoning in a 36-year-old man who experienced hair loss, nail changes, and paresthesias after taking selenium-containing vitamin tablets.

This review discusses the various skin, mucosa, and adnexa side effects associated with different chemotherapeutic agents and provides insights into their clinical presentation and management; it reports no new results.

Nail color change might be an early sign of skin pigmentation from minocycline.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

This study identifies various nail changes in alopecia areata, which can affect quality of life, and suggests that while spontaneous improvement is possible, further research is needed to refine treatment strategies.

This study found that oral tofacitinib monotherapy improved nail changes in 73.3% of adults with moderate-to-severe alopecia areata over a median period of 5 months, but nail improvement was not linked to the severity of hair loss or hair regrowth.

This study observed that 78.3% of patients with alopecia areata exhibited nail changes detectable by dermoscopy, notably nail pitting, in contrast to 14.2% of healthy controls, with these changes significantly associated with disease severity, age, and duration.

In this case study, nail changes and skin lesions helped diagnose a 60-year-old man with advanced cardiac amyloidosis, highlighting the importance of considering amyloidosis in differential diagnoses for similar nail abnormalities and assessing for systemic involvement.

In this study, nail changes, particularly pitting, were associated with moderate to severe cases of alopecia areata and a positive family history, highlighting potential genetic factors in the condition.

This study found that hair and nails can effectively measure hormone changes such as testosterone, estrogen, and progesterone during the peripubertal period in dogs, with variations observed between males and females at specific developmental stages.